Association of Pre-diagnostic Antibody Responses to Escherichia coli and Bacteroides fragilis Toxin Proteins with Colorectal Cancer in a European Cohort.
Julia Butt, Mazda Jenab, Jill Werner, Veronika Fedirko, Elisabete Weiderpass, Christina C Dahm, Anne Tjønneland, Anja Olsen, Marie-Christine Boutron-Ruault, Joseph A Rothwell, Gianluca Severi, Rudolf Kaaks, Renée Turzanski-Fortner, Krasimira Aleksandrova, Matthias Schulze, Domenico Palli, Valeria Pala, Salvatore Panico, Rosario Tumino, Carlotta Sacerdote, Bas Bueno-de-Mesquita, Carla H Van Gils, Inger Torhild Gram, Marko Lukic, Núria Sala, María José Sánchez Pérez, Eva Ardanaz, María-Dolores Chirlaque, Richard Palmquist, Thyra Löwenmark, Ruth C Travis, Alicia Heath, Amanda J Cross, Heinz Freisling, Semi Zouiouich, Elom Aglago, Tim Waterboer, David J Hughes
Journal: Gut microbes
2022;13(1):1-14
PMID: 33874856
Abstract
Experimental evidence has implicated genotoxic () and enterotoxigenic (ETBF) in the development of colorectal cancer (CRC). However, evidence from epidemiological studies is sparse. We therefore assessed the association of serological markers of and ETBF exposure with odds of developing CRC in the European Prospective Investigation into Nutrition and Cancer (EPIC) study.Serum samples of incident CRC cases and matched controls (n = 442 pairs) were analyzed for immunoglobulin (Ig) A and G antibody responses to seven proteins and two isoforms of the ETBF toxin via multiplex serology. Multivariable-adjusted conditional logistic regression analyses were used to estimate odds ratios (ORs) and 95% confidence intervals (CIs) for the association of sero-positivity to and ETBF with CRC.The IgA-positivity of any of the tested antigens was associated with higher odds of developing CRC (OR: 1.42; 95% CI: 1.05-1.91). Dual-positivity for both IgA and IgG to and ETBF was associated with >1.7-fold higher odds of developing CRC, with a significant association only for IgG (OR: 1.75; 95% CI: 1.04, 2.94). This association was more pronounced when restricted to the proximal colon cancers (OR: 2.62; 95% CI: 1.09, 6.29) compared to those of the distal colon (OR: 1.24; 95% CI: 0.51, 3.00) (= 0.095). Sero-positivity to and ETBF was associated with CRC development, suggesting that co-infection of these bacterial species may contribute to colorectal carcinogenesis. These findings warrant further exploration in larger prospective studies and within different population groups.
Address:
Infections and Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Nutrition and Metabolism Branch, International Agency for Research on Cancer (IARC-WHO), Lyon, France.; Department of Public Health, Aarhus University, Aarhus, Denmark.; Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA.; Exposome and Heredity Team, CESP (Centre de Recherche en Epidemiologie et Santé des Populations), Danish Cancer Society Research Center, Diet, Genes and Environment, Nutrition and Biomarkers (NAB), Copenhagen, Denmark.; Department of Public Health, University of Copenhagen, Denmark.; Exposome and Heredity Team, CESP (Centre de Recherche en Epidemiologie et Santé des Populations), Danish Cancer Society Research Center, Diet, Genes and Environment, Nutrition and Biomarkers (NAB), Copenhagen, Denmark.; Department of Public Health, University of Aarhus, Denmark.; Cesp (Umr1018), Médecine Université Paris-Saclay, Inserm, Gustave Roussy, Villejuif, France.; Cesp (Umr1018), Médecine Université Paris-Saclay, Inserm, Gustave Roussy, Villejuif, France.; Department of Statistics, Computer Science and Applications (DISIA), University of Florence, Italy.; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Nutrition and Gerontology, German Institute of Human Nutrition Potsdam-Rehbruecke, Germany.; Department of Molecular Epidemiology, German Institute of Human Nutrition, Potsdam-Rehbruecke, Nuthetal, Germany.; Institute of Nutritional Science, University of Potsdam, Nuthetal, Germany.; Institute for Cancer Research, Prevention and Clinical Network - ISPRO, Florence, Italy.; Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.; Dipartimento Di Medicina Clinica E Chirurgia, Federico II University, Naples, Italy.; Cancer Registry and Histopathology Department, Provincial Health Authority (ASP 7), Ragusa, Italy.; Unit of Cancer Epidemiology, Città Della Salute E Della Scienza University-Hospital, Turin, Italy.; Former Senior Scientist, Dept. For Determinants of Chronic Diseases (DCD), National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.; Former Associate Professor, Department of Gastroenterology and Hepatology, University Medical Centre, Utrecht, The Netherlands.; Former Visiting Professor, Dept. Of Epidemiology and Biostatistics, The School of Public Health, Imperial College London, London, UK.; Former Academic Icon/visiting Professor, Dept. Of Social & Preventive Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.; Julius Centre for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht University, Utrecht, The Netherlands.; Department of Community Medicine, University of Tromsø, the Arctic University of Norway, Tromsø, Norway.; Department of Community Medicine, UiT, The Arctic University of Norway, Tromsø, Norway.; Unit of Nutrition, Environment and Cancer, Cancer Epidemiology Research Program and Translational Research Laboratory, Catalan Institute of Oncology (ICO), Biomedical Research Institute (IDIBELL), Barcelona, Spain.; Escuela Andaluza De Salud Pública (EASP), Granada, Spain.; Instituto De Investigación Biosanitaria ibs.GRANADA, Granada, Spain.; Centro De Investigación Biomédica En Red De Epidemiología Y Salud Pública (CIBERESP), Madrid, Spain.; Department of Preventive Medicine and Public Health, University of Granada, Granada, Spain.; Navarra Public Health Institute, Pamplona, Spain.; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.; CIBER Epidemiology and Public Health CIBERESP, Madrid, Spain.; Department of Epidemiology, Regional Health Council, IMIB-Arrixaca, Murcia University, Murcia, Spain.; CIBER in Epidemiology and Public Health (CIBERESP), Madrid, Spain.; Department of Medical Biosciences, Pathology, Umeå University, Ireland.; Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.; Cancer Biology and Therapeutics Group, School of Biomolecular and Biomedical Science, UCD Conway Institute, University College Dublin, Dublin, Ireland.
Link outs
Free resources
Full Text Sources:
Medical:
Other Literature Sources:
Miscellaneous:
MeSH Terms:
Adult,
Aged,
Antibodies, Bacterial,
Antigens, Bacterial,
Bacterial Toxins,
Bacteroides Infections,
Biomarkers, Tumor,
Colon,
Colorectal Neoplasms,
Escherichia coli,
Escherichia coli Infections,
Europe,
Female,
Humans,
Male,
Metalloendopeptidases,
Middle Aged,
Odds Ratio,
Prospective Studies
